盟科药业-U大幅上涨，公司非公开发行预案披露

Group 1 - The core point of the article is that Amgen Pharmaceuticals has seen a significant stock price increase of 9.89% as of 9:34 AM, with a trading volume of 99.81 million yuan and a turnover rate of 2.17% [2] - The company has announced a non-public issuance plan, intending to issue up to 164 million shares at a price of 6.30 yuan per share, aiming to raise approximately 1.033 billion yuan for daily research and operational investments [2] - Following the completion of this issuance, Nanjing Haiqing Pharmaceutical Co., Ltd. will become the controlling shareholder of the company [2] Group 2 - As of September 22, the margin trading data shows a total margin balance of 85.05 million yuan, with a financing balance of 85.05 million yuan, indicating a decrease of 4.65% over the past five days, amounting to a reduction of 4.15 million yuan [2] - The company's semi-annual report released on August 20 indicates that it achieved a revenue of 66.97 million yuan in the first half of the year, representing a year-on-year growth of 10.26%, while the net profit was -139 million yuan, reflecting a year-on-year increase of 31.11% [2]